x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Orphan designation - Europe

  • Substance: Autologous CD4+ and CD8+ T cells expressing a CD19-specific chimeric antigen receptor
  • ATC code : -
  • EU Number: EU/3/17/1890
  • Designation date : 17/07/2017
  • Sponsor of orphan designation : CELGENE EUROPE LIMITED
  • Summary of Opinion

Designation

Treatment of diffuse large B-cell lymphoma.

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.